Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial – The KADS study

Mary Lou Chatterton, Johana Kevin Perez, Thao Thai, Jan Faller, Colleen K. Loo, Nick Glozier, David Barton, Bernhard T. Baune, Natalie T. Mills, Paul B. Fitzgerald, Paul Glue, Shanthi Sarma, Dusan Hadzi-Pavlovic, Vanessa Dong, Donel Martin, Philip B. Mitchell, Michael Berk, Gregory Carter, Maree Hackett, Sean Hood, Andrew A. Somogyi, Anthony Rodgers, Cathrine Mihalopoulos

Open source

DOI: 10.1016/j.jad.2025.119502
Published: 2025-10
Container: Journal of Affective Disorders
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jad.2025.119502,
  title = {Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial – The KADS study},
  author = {Mary Lou Chatterton and Johana Kevin Perez and Thao Thai and Jan Faller and Colleen K. Loo and Nick Glozier and David Barton and Bernhard T. Baune and Natalie T. Mills and Paul B. Fitzgerald and Paul Glue and Shanthi Sarma and Dusan Hadzi-Pavlovic and Vanessa Dong and Donel Martin and Philip B. Mitchell and Michael Berk and Gregory Carter and Maree Hackett and Sean Hood and Andrew A. Somogyi and Anthony Rodgers and Cathrine Mihalopoulos},
  year = {2025},
  journal = {Journal of Affective Disorders},
  doi = {10.1016/j.jad.2025.119502},
  url = {https://doi.org/10.1016/j.jad.2025.119502}
}

RIS

TY  - JOUR
TI  - Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial – The KADS study
AU  - Mary Lou Chatterton
AU  - Johana Kevin Perez
AU  - Thao Thai
AU  - Jan Faller
AU  - Colleen K. Loo
AU  - Nick Glozier
AU  - David Barton
AU  - Bernhard T. Baune
AU  - Natalie T. Mills
AU  - Paul B. Fitzgerald
AU  - Paul Glue
AU  - Shanthi Sarma
AU  - Dusan Hadzi-Pavlovic
AU  - Vanessa Dong
AU  - Donel Martin
AU  - Philip B. Mitchell
AU  - Michael Berk
AU  - Gregory Carter
AU  - Maree Hackett
AU  - Sean Hood
AU  - Andrew A. Somogyi
AU  - Anthony Rodgers
AU  - Cathrine Mihalopoulos
PY  - 2025
JO  - Journal of Affective Disorders
DO  - 10.1016/j.jad.2025.119502
UR  - https://doi.org/10.1016/j.jad.2025.119502
ER  -

APA

Chatterton, M. L., Perez, J. K., Thai, T., Faller, J., Loo, C. K., Glozier, N., Barton, D., Baune, B. T., Mills, N. T., Fitzgerald, P. B., Glue, P., Sarma, S., Hadzi-Pavlovic, D., Dong, V., Martin, D., Mitchell, P. B., Berk, M., Carter, G., Hackett, M., Hood, S., Somogyi, A. A., Rodgers, A., & Mihalopoulos, C. (2025). Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial – The KADS study. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.119502

Source records

crossref · retrieved 2026-09-25T12:10:21.166Z